A1428 — Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug
Last action — Passed Senate
-
✓Introduced
-
✓In Committee
-
3Passed Assembly
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has passed the Assembly. Introduced January 09, 2025. It now moves to the second chamber.
Next likely step: consideration and a floor vote in the Senate.
Odds of enactment
High chanceBased on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
Passed Assembly
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
-
Cleared a recorded vote
Passed 1 recorded vote so far.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
In plain language
Insurers must cover brand name drugs when generic supply issues are declared by the FDA.
This bill mandates that insurance companies provide coverage for brand name prescription medications if the FDA indicates there is a shortage of the corresponding generic drug. This aims to ensure patients have access to necessary medications during supply shortages.
What this means for you
- Consumers: If you're a patient, this means you may have your brand name medications covered when generics are unavailable.
Summary
Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.
Bill Text
- Full text View text Current
Action History
-
RETURNED TO ASSEMBLY
-
PASSED SENATE
-
3RD READING CAL.1489
-
SUBSTITUTED FOR S9497
-
REFERRED TO INSURANCE
-
DELIVERED TO SENATE
-
PASSED ASSEMBLY
-
ADVANCED TO THIRD READING CAL.311
-
REPORTED
-
REFERRED TO INSURANCE
-
REFERRED TO INSURANCE
Sponsors
- Phara Souffrant Forrest · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 218 not signed on · 10 voted No
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (218)
218 members have not signed on to this bill.
Show all 218 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 50 | 10 | 0 | 3 |
| Total | 50 | 10 | 0 | 3 |
| % of votes cast | 79% | 16% | 0% | 5% |
How each member voted (63)
Subjects
Frequently asked questions
- What does A1428 do?
- Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.
- Who sponsors A1428?
- A1428 is sponsored by Phara Souffrant Forrest.
- What is the current status of A1428?
- This bill has passed the Assembly. Introduced January 09, 2025. It now moves to the second chamber.
- Where can I track A1428?
- Track A1428 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on A1428
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of A1428
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →